These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22493979)

  • 61. Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents.
    Beretta GL; Cassinelli G; Pennati M; Zuco V; Gatti L
    Eur J Med Chem; 2017 Dec; 142():271-289. PubMed ID: 28851502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ABC Transporter-Mediated Multidrug-Resistant Cancer.
    Amawi H; Sim HM; Tiwari AK; Ambudkar SV; Shukla S
    Adv Exp Med Biol; 2019; 1141():549-580. PubMed ID: 31571174
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of tyrosine kinase inhibitors with the MDR- related ABC transporter proteins.
    Wang XK; Fu LW
    Curr Drug Metab; 2010 Sep; 11(7):618-28. PubMed ID: 20812904
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Relevance of multidrug resistance in the age of targeted therapy.
    Türk D; Szakács G
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The functions and structure of ABC transporters: implications for the design of new inhibitors of Pgp and MRP1 to control multidrug resistance (MDR).
    Teodori E; Dei S; Martelli C; Scapecchi S; Gualtieri F
    Curr Drug Targets; 2006 Jul; 7(7):893-909. PubMed ID: 16842220
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells.
    Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ
    Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors?
    Hegedus C; Ozvegy-Laczka C; Szakács G; Sarkadi B
    Curr Cancer Drug Targets; 2009 May; 9(3):252-72. PubMed ID: 19442047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Shukla S; Ambudkar SV; Kong D; Chen ZS
    Cancer Lett; 2019 Jan; 440-441():82-93. PubMed ID: 30315846
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ABC transporters and inhibitors: new targets, new agents.
    Leonard GD; Polgar O; Bates SE
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1652-9. PubMed ID: 12476969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.
    Wu S; Fu L
    Mol Cancer; 2018 Feb; 17(1):25. PubMed ID: 29455646
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
    Fruci D; Cho WC; Nobili V; Locatelli F; Alisi A
    Curr Drug Metab; 2016; 17(4):308-16. PubMed ID: 26694726
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2.
    Silbermann K; Shah CP; Sahu NU; Juvale K; Stefan SM; Kharkar PS; Wiese M
    Eur J Med Chem; 2019 Feb; 164():193-213. PubMed ID: 30594677
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
    Adamska A; Falasca M
    World J Gastroenterol; 2018 Aug; 24(29):3222-3238. PubMed ID: 30090003
    [TBL] [Abstract][Full Text] [Related]  

  • 74. ABC transporter superfamily. An updated overview, relevance in cancer multidrug resistance and perspectives with personalized medicine.
    Juan-Carlos PM; Perla-Lidia PP; Stephanie-Talia MM; Mónica-Griselda AM; Luz-María TE
    Mol Biol Rep; 2021 Feb; 48(2):1883-1901. PubMed ID: 33616835
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pleiotropic Roles of ABC Transporters in Breast Cancer.
    He J; Fortunati E; Liu DX; Li Y
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801148
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans.
    Chambers CS; Viktorová J; Řehořová K; Biedermann D; Turková L; Macek T; Křen V; Valentová K
    J Agric Food Chem; 2020 Feb; 68(7):1763-1779. PubMed ID: 30907588
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells.
    Lowrence RC; Subramaniapillai SG; Ulaganathan V; Nagarajan S
    Crit Rev Microbiol; 2019 May; 45(3):334-353. PubMed ID: 31248314
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting multidrug resistance in cancer.
    Szakács G; Paterson JK; Ludwig JA; Booth-Genthe C; Gottesman MM
    Nat Rev Drug Discov; 2006 Mar; 5(3):219-34. PubMed ID: 16518375
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeted disruption of mitochondria potently reverses multidrug resistance in cancer therapy.
    Liu D; Rong H; Chen Y; Wang Q; Qian S; Ji Y; Yao W; Yin J; Gao X
    Br J Pharmacol; 2022 Jul; 179(13):3346-3362. PubMed ID: 35040123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel Potent ABCB1 Modulator, Phenethylisoquinoline Alkaloid, Reverses Multidrug Resistance in Cancer Cell.
    Sugisawa N; Ohnuma S; Ueda H; Murakami M; Sugiyama K; Ohsawa K; Kano K; Tokuyama H; Doi T; Aoki J; Ishida M; Kudoh K; Naitoh T; Ambudkar SV; Unno M
    Mol Pharm; 2018 Sep; 15(9):4021-4030. PubMed ID: 30052463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.